6.7100
29-November-24 13:30:00
15 minutes delayed
Stocks
+0.1700
+2.60%
Today's range
6.5000 - 6.7500
ISIN
N/A
Source
NYSE
Annovis Bio Announces Issuance of U.S. Patent Covering the Use of Lead Drug Candidate, Buntanetap, for Prevention or Treatment of Disease States Due to Metal Dis-Homeostasis in Healthy or Sick Humans
27 Apr 2023 07:00:00 By Nasdaq GlobeNewswire
Annovis Bio, Inc. to present at the Q1 Virtual Investor Summit
11 Mar 2021 07:05:00 By Nasdaq GlobeNewswire
Annovis Bio to Present at the BIO CEO & Investor Digital Conference
16 Feb 2021 06:45:00 By Nasdaq GlobeNewswire